Back
Replimune Group Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
29
REPL
Replimune Group
Last Price:
12.65
Seasonality Move:
-15.42%
Sell
48
BMY
Bristol-Myers Squibb
Last Price:
56.65
Seasonality Move:
1.32%
Sell
29
Replimune Group (REPL)
is a Sell
Is Replimune Group a Buy, Sell or Hold?
- The current Replimune Group [REPL] share price is $12.64. The Score for REPL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- REPL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $56.65. The Score for BMY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REPL Stock Price Chart
What is Replimune Group's stock price today?
-
The Replimune Group share price today is $12.64
The current trend is moderately bearish and REPL is experiencing selling pressure, which indicates risk of future bearish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $56.65
The current trend is moderately bearish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
REPL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 50.11 | Buy |
Chaikin Money Flow: | -412486 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.47 - 13.71) | Buy |
Bollinger Bands (100): | (10.06 - 12.42) | Buy |
BMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.76 | Buy |
Relative Strength Index (14 RSI): | 45.81 | Sell |
Chaikin Money Flow: | -9354550 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.52 - 59.54) | Sell |
Bollinger Bands (100): | (47.88 - 56.34) | Buy |
REPL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.01 | Sell |
20-day SMA: | 12.64 | Buy |
50-day SMA: | 12.14 | Buy |
200-day SMA: | 9.46 | Buy |
8-day EMA: | 12.94 | Sell |
20-day EMA: | 12.78 | Sell |
50-day EMA: | 12.16 | Buy |
200-day EMA: | 10.92 | Buy |
BMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.59 | Sell |
20-day SMA: | 58.39 | Sell |
50-day SMA: | 55.66 | Buy |
200-day SMA: | 49.04 | Buy |
8-day EMA: | 58.24 | Sell |
20-day EMA: | 57.94 | Sell |
50-day EMA: | 55.76 | Buy |
200-day EMA: | 51.7 | Buy |
Replimune Group Earnings Growth & REPL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.52 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.48 per share, and an increase next year of $6.15 per share.
Replimune Group Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bristol-Myers Squibb Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |